Home / Drug shortages / Dobutamine Hydrochloride Injection

Dobutamine Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Dobutamine Hydrochloride Injection (injection) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on 08/27/2025.

Shortage Details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0409-2344-88
Dosage Form
Injection
Presentation
Dobutamine Hydrochloride, Injection, 12.5 mg/1 mL (NDC 0409-2344-88)
Initial Posting
08/27/2025
Revised Date

FDA data resources